Literature DB >> 24261127

Serum iron and ferritin level in idiopathic Parkinson.

Mehdi Farhoudi1, Aliakbar Taheraghdam, Gholnar Abbasi Farid, Mahnaz Talebi, Ali Pashapou, Jafar Majidi, Mohamad Goldust.   

Abstract

Parkinson disease is a prevalent progressive neurodegenerative disorder, especially in western countries and among the elderly. This study aimed at evaluating serum iron and ferritin in patients with idiopathic Parkinson disease. In this case-control study, 50 patients with clinical diagnosis of idiopathic Parkinson disease (case group) were evaluated during a 12 month period. Fifty healthy persons (control group) recruited as well. Serum iron and ferritin levels were measured by biochemical and quantitative luminance methods, respectively in the case and control group. Fifty patients, 28 males and 22 females with the mean age of 64.53 +/- 10.18 (40-84) years and 50 controls were enrolled. Serum iron levels were 70.22 +/- 25.18 mg dL(-1) and 67.62 +/- 39.53 mg dL(-1) in case and control group, respectively. Serum ferritin levels were 129.79 +/- 137.67 ng dL(-1) and 109.87 +/- 154.71 ng dL(-1) in case and control group, respectively. There was no significant difference between different grades of Parkinson disease considering the serum level of iron or ferritin. The current study showed that generally there is no significant difference between the patients with the idiopathic Parkinson disease and healthy controls in terms of serum iron and ferritin levels. The same results were attributable to different grades of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24261127     DOI: 10.3923/pjbs.2012.1094.1097

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  8 in total

1.  Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD.

Authors:  Yang Hu; Shu-Yang Yu; Li-Jun Zuo; Ying-Shan Piao; Chen-Jie Cao; Fang Wang; Ze-Jie Chen; Yang Du; Teng-Hong Lian; Gai-Fen Liu; Ya-Jie Wang; Piu Chan; Sheng-Di Chen; Xiao-Min Wang; Wei Zhang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

2.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

3.  COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Authors:  Diego Santos-García; Pablo Mir; Esther Cubo; Lydia Vela; Mari Cruz Rodríguez-Oroz; Maria José Martí; José Matías Arbelo; Jon Infante; Jaime Kulisevsky; Pablo Martínez-Martín
Journal:  BMC Neurol       Date:  2016-02-25       Impact factor: 2.474

Review 4.  Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.

Authors:  Jian-Yong Wang; Qing-Qing Zhuang; Lan-Bing Zhu; Hui Zhu; Ting Li; Rui Li; Song-Fang Chen; Chen-Ping Huang; Xiong Zhang; Jian-Hong Zhu
Journal:  Sci Rep       Date:  2016-11-09       Impact factor: 4.379

Review 5.  Environmental Exposures and Parkinson's Disease.

Authors:  Sirisha Nandipati; Irene Litvan
Journal:  Int J Environ Res Public Health       Date:  2016-09-03       Impact factor: 3.390

6.  Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson's Disease.

Authors:  Xiaoli Shen; Huazhen Yang; Dongfeng Zhang; Hong Jiang
Journal:  Front Neurosci       Date:  2019-09-26       Impact factor: 4.677

7.  Evidence-Based Discriminant Analysis: A New Insight into Iron Profile for the Diagnosis of Parkinson's Disease.

Authors:  Chandra Bhushan Tripathi; Mohit Gangania; Suman Kushwaha; Rachna Agarwal
Journal:  Ann Indian Acad Neurol       Date:  2021-04-06       Impact factor: 1.383

8.  Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson's Disease.

Authors:  Yang Hu; Peng Guo; Teng-Hong Lian; Li-Jun Zuo; Shu-Yang Yu; Li Liu; Zhao Jin; Qiu-Jin Yu; Rui-Dan Wang; Li-Xia Li; Ying-Shan Piao; Wei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-21       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.